Role for KAP1 Serine 824 Phosphorylation and Sumoylation/desumoylation Switch in Regulating KAP1-mediated Transcriptional Repression
Overview
Affiliations
As a multifunctional protein, KRAB domain-associated protein 1 (KAP1) is reportedly subjected to multiple protein posttranslational modifications, including phosphorylation and sumoylation. However, gaps exist in our knowledge of how KAP1 phosphorylation cross-talks with KAP1 sumoylation and what the biological consequence is. Here, we show that doxorubicin (Dox) treatment induces KAP1 phosphorylation at Ser-824 via an ataxia telangiectasia mutated (ATM)-dependent manner, correlating with the transcriptional de-repression of p21WAF1/CIP1 and Gadd45alpha. A S824A substitution of KAP1, which ablates the ATM-induced phosphorylation, results in an increase of KAP1 sumoylation and repression of p21 transcription in Dox-treated cells. By contrast, a S824D mutation of KAP1, which mimics constitutive phosphorylation of KAP1, leads to a decrease of KAP1 sumoylation and stimulation of p21 transcription before the exposure of Dox. We further provide evidence that SENP1 deSUMOylase is involved in activating basal, but not Dox-induced, KAP1 Ser-824 phosphorylation, rendering a stimulation of p21 and Gadd45alpha transcription. Moreover, KAP1 and differential sumoylation of KAP1 were also demonstrated to fine-tune the transcription of three additional KAP1-targeted genes, including Bax, Puma, and Noxa. Taken together, our results suggest a novel role for ATM that selectively stimulates KAP1 Ser-824 phosphorylation to repress its sumoylation, leading to the de-repression of expression of a subset of genes involved in promoting cell cycle control and apoptosis in response to genotoxic stresses.
Sharma A, Tyagi P, Khumallambam M, Tyagi M Cells. 2024; 13(23).
PMID: 39682697 PMC: 11640508. DOI: 10.3390/cells13231950.
Ip W, Fiedler M, Gornott B, Morische M, Bertzbach L, Dobner T Front Cell Infect Microbiol. 2024; 14:1484241.
PMID: 39397864 PMC: 11466889. DOI: 10.3389/fcimb.2024.1484241.
PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma.
Gaballa A, Gebhardt-Wolf A, Krenz B, Mattavelli G, John M, Cossa G Nat Commun. 2024; 15(1):1446.
PMID: 38365788 PMC: 10873513. DOI: 10.1038/s41467-024-45760-8.
Ning T, Zhao M, Zhang N, Wang Z, Zhang S, Liu M Exp Biol Med (Maywood). 2023; 248(23):2210-2218.
PMID: 38058023 PMC: 10903244. DOI: 10.1177/15353702231211970.
Godneeva B, Ninova M, Fejes-Toth K, Aravin A Elife. 2023; 12.
PMID: 37999956 PMC: 10672805. DOI: 10.7554/eLife.89493.